Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000253897 is annotated as a **pseudogene** related to the solute carrier family 36 (SLC36). Pseudogenes are noncoding genomic DNA sequences that resemble known genes but are non-functional due to mutations, deletions, or insertions, preventing them from producing functional proteins. As such, this locus is not a functional transporter, receptor, enzyme, or any class of bona fide therapeutic target. It should not be considered a candidate for drug discovery or biomarker development. The "solute carrier" (SLC) family, in general, comprises transporter proteins involved in the transmembrane movement of various solutes, but a pseudogene does not encode a functional protein capable of transporter activity[2][3][4][6]. **Clarification:** - This gene entry encodes a **pseudogene**, not a functional member of SLC36 (such as SLC36A1 or SLC36A4, which are true amino acid transporters)[1][5]. - Pseudogenes are not valid targets for therapeutic intervention and generally have no known biological function or disease role. - The presence of "solute carrier family 36" in the name reflects sequence similarity, not function—no transmembrane transporter is produced. If additional therapeutic, biological, or pharmacological information is required, it is necessary to refer to a protein-coding SLC36 family gene such as **Solute carrier family 36 member 1 (SLC36A1, ENSG00000123643)** or **Solute carrier family 36 member 4 (SLC36A4, ENSG00000180773)**[1][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier family 36 pseudogene.